Head to Head Review: Aimei Health Technology (AFJK) and The Competition

Aimei Health Technology (NASDAQ:AFJK) is one of 89 public companies in the “UNCLASSIFIED” industry, but how does it compare to its rivals? We will compare Aimei Health Technology to similar businesses based on the strength of its risk, valuation, earnings, profitability, dividends, analyst recommendations and institutional ownership.

Volatility & Risk

Aimei Health Technology has a beta of -0.02, meaning that its share price is 102% less volatile than the S&P 500. Comparatively, Aimei Health Technology’s rivals have a beta of -0.08, meaning that their average share price is 108% less volatile than the S&P 500.

Profitability

This table compares Aimei Health Technology and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Aimei Health Technology	N/A	-95.88%	3.06%
Aimei Health Technology Competitors	0.86%	0.95%	0.80%

Valuation and Earnings

This table compares Aimei Health Technology and its rivals gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Aimei Health Technology	N/A	$2.55 million	52.52
Aimei Health Technology Competitors	$41.37 million	-$18.54 million	93.19

Aimei Health Technology’s rivals have higher revenue, but lower earnings than Aimei Health Technology. Aimei Health Technology is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Analyst Ratings

This is a summary of current ratings and target prices for Aimei Health Technology and its rivals, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aimei Health Technology	0	1	0	0	2.00
Aimei Health Technology Competitors	225	265	217	3	2.00

As a group, “UNCLASSIFIED” companies have a potential upside of 96.81%. Given Aimei Health Technology’s rivals higher possible upside, analysts clearly believe Aimei Health Technology has less favorable growth aspects than its rivals.

Institutional and Insider Ownership

45.6% of Aimei Health Technology shares are held by institutional investors. Comparatively, 52.0% of shares of all “UNCLASSIFIED” companies are held by institutional investors. 2.5% of Aimei Health Technology shares are held by insiders. Comparatively, 42.9% of shares of all “UNCLASSIFIED” companies are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Aimei Health Technology rivals beat Aimei Health Technology on 9 of the 13 factors compared.

Aimei Health Technology Company Profile

Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.